Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm	Recruiting	Phase 2	2025-12-16		NCT07285590

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370
Evidenze CRO	5
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea	6

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Clínica Universidad Navarra	Pamplona	Spain	1
Clínica Universidad Navarra	Madrid	Spain	1
Hospital Clinic de Barcelona	Barcelona	Spain	19
Hospital Clínico de Valencia	Valencia	Spain	9
Hospital Clínico Universitario Virgen de la Arrixaca	El Palmar	Spain	14
Hospital Costa del Sol	Marbella	Spain	4
Hospital General Universitario Gregorio Marañón	Madrid	Spain	25
Hospital Ramon y Cajal	Madrid	Spain	2
Hospital Universitari Vall d'Hebron	Barcelona	Spain	22
Hospital Universitario 12 de Octubre	Madrid	Spain	55
Hospital Universitario de Salamanca	Salamanca	Spain	7
Hospital Universitario y Politécnico La Fe	Valencia	Spain	20
INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol.	Badalona	Spain	1
Institut Català d'oncologia de L'Hospitalet (ICO-L'Hospitalet)	L'Hospitalet de Llobregat	Spain	1
Instituto Português de Oncologia de Lisboa Francisco Gentil	Lisbon	Portugal	6
Unidade Local De Saude De Santa Maria E.P.E.	Lisbon	Portugal	1